JPH07505880A - 抗菌作用の増強剤 - Google Patents
抗菌作用の増強剤Info
- Publication number
- JPH07505880A JPH07505880A JP5518221A JP51822193A JPH07505880A JP H07505880 A JPH07505880 A JP H07505880A JP 5518221 A JP5518221 A JP 5518221A JP 51822193 A JP51822193 A JP 51822193A JP H07505880 A JPH07505880 A JP H07505880A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- antibacterial
- monoglyceride
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Description
Claims (18)
- 1.A)ラウリン酸のモノグリセリド、モノミリスチン酸のモノグリセリドまた はこれらのモノグリセリドの混合物、B)i)アミド型の局所麻酔剤 ii)カルバミド iii)ステロイド抗生物質、イミダゾール誘導体またはニトロイミダゾール誘 導体の形態の抗菌物質、およびiv)炭素原子3〜6個を有するジオールよりな る群から選択される化学物質少なくとも1種、およびC)場合により、従来の生 理学的に許容される担体および/または生理学的に許容される添加物 の組合わせの抗菌的に有効な量を含有することを特徴とする抗菌組成物。
- 2.アミド型の局所麻酔剤がリドカイン、プリロカイン、メピバカイン、シンコ カイン、ブピバカインおよびエチドカインよりなる群から選択されることを特徴 とする請求項1記載の組成物。
- 3.アミド型の局所麻酔剤がリドカインであることを特徴とする請求項2記載の 組成物。
- 4.ステロイド抗生物質の形態の抗菌物質がフシジン酸またはセファロスポリン であることを特徴とする請求項1〜3の何れかに記載の組成物。
- 5.抗菌物質がフシジン酸であることを特徴とする請求項4記載の組成物。
- 6.イミダゾール誘導体が硝酸エコナゾールまたは硝酸ミコナゾールであること を特徴とする請求項1〜5の何れか1項に記載の組成物。
- 7.イミダゾール誘導体が硝酸エコナゾールであることを特徴とする請求項6記 載の組成物。
- 8.ニトロイミダゾール誘導体がチニダゾールまたはメトロニダゾールであるこ とを特徴とする前記した請求項の何れか1項に記載の組成物。
- 9.炭素原子3〜6個を有するジオールがペンタンジオール、好ましくは1,5 −ペンタンジオールであることを特徴とする前記した請求項の何れか1項に記載 の組成物。
- 10.モノグリセリドA)がモノラウレート、好ましくは1−グリセロールモノ ラウレートまたは3−グリセロールモノラウレートであることを特徴とする前記 した請求項の何れか1項に記載の組成物。
- 11.総組成物の重量を基に計算してモノグリセリドA)少なくとも0.2pp mを含有することを特徴とする前記した請求項の何れか1項に記載の組成物。
- 12.総組成物の重量に対する重量として計算してA)の濃度が0.2ppm〜 30%であることを特徴とする前記した請求項の何れか1項に記載の組成物。
- 13.組成物の総重量を基にした重量として計算して、化学物質B)を1ppm 〜20%、好ましくは1ppm〜10%、あるいは0.1〜20%、特に0.1 〜m重量%を含有することを特徴とする前記した請求項の何れか1項に記載の組 成物。
- 14.モノグリセリドA)を、場合により担体および/または添加物C)の存在 下、脂質の遷移または転移温度より高温に加熱し、物質B)を変換が起こるまで 加熱混合物に添加し、そして物質B)含有混合物を室温程度まで冷却することを 特徴とする請求項1〜13の何れか1項に記載の抗菌組成物の調製方法。
- 15.冷却を約1〜3℃/分の速度で行うことを特徴とする請求項13記載の方 法。
- 16.抗菌医薬組成物として使用するための請求項1〜13の何れか1項に記載 の組成物。
- 17.細菌およびカビを殺滅するための皮膚科用製剤の調製のための請求項1〜 13の何れか1項に記載の組成物の使用。
- 18.化粧品、食品または医薬品中の保存料としての請求項1〜13の何れか1 項に記載の組成物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201187-3 | 1992-04-14 | ||
SE9201187A SE500777C2 (sv) | 1992-04-14 | 1992-04-14 | Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav |
PCT/SE1993/000275 WO1993020812A1 (en) | 1992-04-14 | 1993-03-31 | Potentiation of antimicrobial effects |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07505880A true JPH07505880A (ja) | 1995-06-29 |
JP4014114B2 JP4014114B2 (ja) | 2007-11-28 |
Family
ID=20385960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51822193A Expired - Lifetime JP4014114B2 (ja) | 1992-04-14 | 1993-03-31 | 抗菌作用の増強剤 |
Country Status (15)
Country | Link |
---|---|
US (1) | US5550145A (ja) |
EP (1) | EP0636024B1 (ja) |
JP (1) | JP4014114B2 (ja) |
AT (1) | ATE181502T1 (ja) |
AU (1) | AU677580B2 (ja) |
CA (1) | CA2118114C (ja) |
DE (1) | DE69325450T2 (ja) |
DK (1) | DK0636024T3 (ja) |
ES (1) | ES2132230T3 (ja) |
GR (1) | GR3030999T3 (ja) |
HK (1) | HK1007923A1 (ja) |
NZ (1) | NZ251783A (ja) |
SE (1) | SE500777C2 (ja) |
SG (1) | SG52341A1 (ja) |
WO (1) | WO1993020812A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533052A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 抗ウイルス性組成物および使用方法 |
JP2014512408A (ja) * | 2011-04-29 | 2014-05-22 | エフィック ソシエテ アノニム | アルキルポリグルコシドをベースとする膣用組成物 |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411899A1 (de) * | 1994-04-07 | 1995-10-12 | Beiersdorf Ag | Gegen Fußgeruch wirksame Zubereitungen mit einem Gehalt an Monoglycerinestern von Fettsäuren |
CN1159158A (zh) * | 1994-05-20 | 1997-09-10 | 诺瓦瓦克斯有限公司 | 抗菌水包油乳液 |
US5460802A (en) * | 1994-07-18 | 1995-10-24 | Minnesota Mining And Manufacturing Company | Oral disinfectant for companion animals |
DE4434781A1 (de) * | 1994-09-29 | 1996-04-04 | Beiersdorf Ag | Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen |
DE4434775A1 (de) * | 1994-09-29 | 1996-04-04 | Beiersdorf Ag | Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen |
DE4435290A1 (de) * | 1994-10-01 | 1996-04-04 | Beiersdorf Ag | Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen |
DE4436537A1 (de) * | 1994-10-13 | 1996-04-18 | Beiersdorf Ag | Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen |
DE4438588A1 (de) * | 1994-10-28 | 1996-05-02 | Beiersdorf Ag | Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren |
DE4444237C2 (de) * | 1994-12-13 | 2000-08-24 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne |
DE19540465A1 (de) * | 1995-10-30 | 1997-05-07 | Beiersdorf Ag | Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden |
US5700842A (en) * | 1995-11-01 | 1997-12-23 | Kimberly-Clark Worldwide, Inc. | Methods of incorporating a hydrophobic substance into an aqueous solution |
DE19541967A1 (de) * | 1995-11-10 | 1997-05-15 | Beiersdorf Ag | Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Partialglyceriden und Arylverbindungen |
ES2157131T3 (es) | 1998-02-12 | 2001-08-01 | Oreal | Utilizacion del 1,2-pentanodiol en una composicion cosmetica o dermatologica que contiene una dispersion acuosa de polimero filmogeno, y composicion cosmetica o dermatologica que comprende estos constituyentes. |
DK1063886T3 (da) | 1998-03-19 | 2003-06-23 | Bifodan As | Desinficerende middel |
NZ509312A (en) * | 1998-06-23 | 2003-11-28 | Univ Maryland | Use of oils having a high lauric acid content as an animal feed |
US6096332A (en) | 1998-06-30 | 2000-08-01 | Mcneil-Ppc, Inc. | Adding pharmaceutically active compounds to substrates |
IT1317735B1 (it) * | 2000-01-26 | 2003-07-15 | Nicox Sa | Sali di agenti antimicrobici. |
US7074832B2 (en) | 2001-09-24 | 2006-07-11 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
US6429231B1 (en) * | 2001-09-24 | 2002-08-06 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
SE0103528D0 (sv) * | 2001-10-21 | 2001-10-21 | Jan Faergeman | Topiska kompositioner med förstärkt effekt |
DE10205190B4 (de) | 2002-02-08 | 2017-06-08 | Beiersdorf Ag | 2-Methyl-1,3-propandiol haltige Zubereitungen |
US20050036972A1 (en) * | 2003-03-10 | 2005-02-17 | Hy-Gene Biomedical Corporation | System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations |
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US7566447B2 (en) * | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
US8394379B2 (en) * | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US20050014932A1 (en) | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
JP4091566B2 (ja) * | 2003-06-03 | 2008-05-28 | 株式会社マンダム | 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品 |
SE0301862D0 (sv) * | 2003-06-26 | 2003-06-26 | Jan Faergeman | Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier |
US7214391B2 (en) * | 2003-06-30 | 2007-05-08 | Usana Health Sciences, Inc. | Botanical extract compositions and process for preparing same |
MY140194A (en) * | 2003-07-16 | 2009-11-30 | Leo Pharma As | Novel fusidic acid derivatives |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
BRPI0414193A (pt) * | 2003-09-09 | 2006-10-31 | 3M Innovative Properties Co | composição antimicrobiana, kit antimicrobiano e métodos de usar a composição e de aplicar uma composição antimicrobiana a um substrato |
EP1672989B1 (en) * | 2003-09-09 | 2012-04-25 | 3M Innovative Properties Company | Concentrated antimicrobial compositions and methods |
WO2005047475A2 (en) * | 2003-11-11 | 2005-05-26 | Regents Of The University Of Minnesota | Regulation of cell membrane-mediated effects |
FR2869802B1 (fr) * | 2004-05-04 | 2010-08-20 | I N E A S L | Composition cosmetique et/ou dermatologique possedant des proprietes conservatrices hypoalergeniques |
US8796332B2 (en) | 2004-08-03 | 2014-08-05 | Regents Of The University Of Minnesota | Compositions and methods for controlling infections |
EP1812550A2 (en) * | 2004-10-20 | 2007-08-01 | Iogenetics, Llc | Biocides |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
US8535709B2 (en) * | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
US20060127437A1 (en) * | 2004-12-13 | 2006-06-15 | Misty Anderson Kennedy | Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids |
US10918618B2 (en) | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
ATE511838T1 (de) | 2005-03-10 | 2011-06-15 | 3M Innovative Properties Co | Antimikrobielle zusammensetzungen mit hydroxycarboxylsäureestern |
EP1868686A2 (en) * | 2005-03-10 | 2007-12-26 | 3M Innovative Properties Company | Antimicrobial pet wipes |
EP1858506A2 (en) | 2005-03-10 | 2007-11-28 | 3M Innovative Properties Company | Methods of treating ear infections |
EP1981477A1 (en) * | 2006-02-02 | 2008-10-22 | Leo Pharma A/S | A topical composition comprising an antibacterial substance |
US20080075793A1 (en) * | 2006-09-21 | 2008-03-27 | Dunshee Wayne K | Antiviral compositions and methods of use |
WO2010047831A1 (en) * | 2008-10-23 | 2010-04-29 | Nycomed Us Inc. | Stable metronidazole gel formulations |
FR2954124B1 (fr) * | 2009-12-18 | 2012-04-06 | Fabre Pierre Dermo Cosmetique | Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee |
US20130165880A1 (en) | 2010-09-17 | 2013-06-27 | David T. Amos | Antimicrobial disposable absorbent articles |
GB201118193D0 (en) | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to oranic compounds |
GB201118198D0 (en) | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to organic compounds |
US20190142800A1 (en) * | 2016-06-13 | 2019-05-16 | Vyome Therapeutics Limited | Synergistic antifungal compositions and methods thereof |
WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK116528A (ja) * | 1966-09-30 | |||
US4067997A (en) * | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
JPS5814758B2 (ja) * | 1977-08-23 | 1983-03-22 | 株式会社日立製作所 | 多層配線基板 |
JPS58111669A (ja) * | 1981-12-25 | 1983-07-02 | Takeda Chem Ind Ltd | 食品用防腐剤および食品の防腐方法 |
CA1331559C (en) * | 1986-04-21 | 1994-08-23 | Jon Joseph Kabara | Antimicrobial preservative compositions and methods |
CA1302280C (en) * | 1986-04-21 | 1992-06-02 | Jon Joseph Kabara | Topical antimicrobial pharmaceutical compositions and methods |
NZ221168A (en) * | 1986-08-15 | 1989-08-29 | Colgate Palmolive Co | Antiseptic composition containing ethyl alcohol and monolaurin |
US4997851A (en) * | 1987-12-31 | 1991-03-05 | Isaacs Charles E | Antiviral and antibacterial activity of fatty acids and monoglycerides |
US4847088A (en) * | 1988-04-28 | 1989-07-11 | Dow Corning Corporation | Synergistic antimicrobial composition |
WO1990010441A1 (en) * | 1989-03-13 | 1990-09-20 | Thornfeldt Carl R | Treatment of skin diseases and tumors |
US5057500A (en) * | 1990-02-12 | 1991-10-15 | Dermatologic Research Corporation | Treatment of pruritis with esters and amides |
EP0593459B1 (en) * | 1990-04-18 | 1997-01-22 | The Procter & Gamble Company | Anti-lice treatment compositions |
FI912955A (fi) * | 1990-06-25 | 1991-12-26 | Res Found Mental Hygiene | Antimikroba fettsyrasammansaettningar. |
NZ250714A (en) * | 1990-10-30 | 1996-05-28 | Mcneil Ppc Inc | Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production |
-
1992
- 1992-04-14 SE SE9201187A patent/SE500777C2/sv unknown
-
1993
- 1993-03-31 US US08/307,763 patent/US5550145A/en not_active Expired - Lifetime
- 1993-03-31 DE DE69325450T patent/DE69325450T2/de not_active Expired - Lifetime
- 1993-03-31 EP EP93909105A patent/EP0636024B1/en not_active Expired - Lifetime
- 1993-03-31 CA CA002118114A patent/CA2118114C/en not_active Expired - Lifetime
- 1993-03-31 SG SG1996003104A patent/SG52341A1/en unknown
- 1993-03-31 AU AU39639/93A patent/AU677580B2/en not_active Expired
- 1993-03-31 AT AT93909105T patent/ATE181502T1/de active
- 1993-03-31 WO PCT/SE1993/000275 patent/WO1993020812A1/en active IP Right Grant
- 1993-03-31 DK DK93909105T patent/DK0636024T3/da active
- 1993-03-31 JP JP51822193A patent/JP4014114B2/ja not_active Expired - Lifetime
- 1993-03-31 NZ NZ251783A patent/NZ251783A/en not_active IP Right Cessation
- 1993-03-31 ES ES93909105T patent/ES2132230T3/es not_active Expired - Lifetime
-
1998
- 1998-07-06 HK HK98108909A patent/HK1007923A1/xx not_active IP Right Cessation
-
1999
- 1999-08-18 GR GR990402077T patent/GR3030999T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533052A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 抗ウイルス性組成物および使用方法 |
JP2014512408A (ja) * | 2011-04-29 | 2014-05-22 | エフィック ソシエテ アノニム | アルキルポリグルコシドをベースとする膣用組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP0636024A1 (en) | 1995-02-01 |
SG52341A1 (en) | 1998-09-28 |
AU677580B2 (en) | 1997-05-01 |
DK0636024T3 (da) | 1999-11-22 |
SE500777C2 (sv) | 1994-08-29 |
EP0636024B1 (en) | 1999-06-23 |
SE9201187L (sv) | 1993-10-15 |
DE69325450T2 (de) | 1999-12-23 |
US5550145A (en) | 1996-08-27 |
WO1993020812A1 (en) | 1993-10-28 |
DE69325450D1 (de) | 1999-07-29 |
JP4014114B2 (ja) | 2007-11-28 |
GR3030999T3 (en) | 1999-12-31 |
CA2118114A1 (en) | 1993-10-28 |
HK1007923A1 (en) | 1999-04-30 |
CA2118114C (en) | 2003-06-17 |
NZ251783A (en) | 1996-07-26 |
SE9201187D0 (sv) | 1992-04-14 |
ES2132230T3 (es) | 1999-08-16 |
ATE181502T1 (de) | 1999-07-15 |
AU3963993A (en) | 1993-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07505880A (ja) | 抗菌作用の増強剤 | |
US4966754A (en) | Preservation of cosmetic compositions | |
US6001864A (en) | Antifungal agent | |
DE60129823T2 (de) | Stickstoffoxid zur behandlung therapieresistenter organismen | |
EP1269983B1 (de) | Verwendung von 1,2-Decandiol gegen Körpergeruch verursachende Keime | |
DE10206759A1 (de) | Synergistische Mischungen von 1,2-Alkandiolen | |
JPH10509437A (ja) | 防臭、抗菌及び保存剤組成物並びにそれらを使用する方法 | |
WO2005000287A1 (ja) | 水虫治療用外用剤 | |
JP2011074082A (ja) | 防腐殺菌剤及び人体施用組成物 | |
KR102272901B1 (ko) | 메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물 | |
JP2004352688A (ja) | 防腐剤組成物 | |
CA2322994A1 (en) | Topical antiseptic compositions and methods | |
DK157781B (da) | Fremgangsmaade til fremstilling af et tretinoinholdigt gelpraeparat til lokal applikation | |
KR102093827B1 (ko) | 폴리(부틸시아노아크릴레이트)를 포함하는 화장료 보존제 조성물 | |
JP5210527B2 (ja) | 防腐殺菌保湿剤及び皮膚・毛髪外用組成物 | |
JPS6241645B2 (ja) | ||
HU194493B (en) | Process for preparing primycin-containing colloidal basic gel and compositions comprising the same | |
JPH09110693A (ja) | 抗真菌剤 | |
JP4734293B2 (ja) | 防腐殺菌剤及び人体施用組成物 | |
US3123528A (en) | New therapeutic compositions | |
US5360788A (en) | Personal care composition containing pyrithione and a basic lipopeptide | |
JP4541661B2 (ja) | 消毒および/または殺菌用組成物 | |
JP2000302674A (ja) | 選択的抗菌組成物 | |
CN109985063A (zh) | 一种高效抑菌药物组合物及其制备方法与应用 | |
EP3482743A1 (de) | Emulsionen zur behandlung von scheideninfektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051004 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051221 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060404 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070109 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070509 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070628 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070814 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070907 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100921 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100921 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110921 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110921 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120921 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120921 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130921 Year of fee payment: 6 |